Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?

被引:15
作者
Beattie, PE [1 ]
Dawe, RS
Traynor, NJ
Woods, JA
Ferguson, J
Ibbotson, SH
机构
[1] Univ Dundee, Ninewells Hosp, Dept Dermatol, Photobiol Unit, Dundee DD1 9SY, Scotland
[2] Med Sch, Dundee DD1 9SY, Scotland
关键词
dose-response; erythema; hypericin; St John's wort; time course; ultraviolet A1;
D O I
10.1111/j.1365-2133.2005.06946.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Background St John's wort (SJW) is widely used as a treatment for depression. A phototoxic reaction, due to its content of hypericin, can occur in animals and in cell culture, and has been reported in humans. Hypericin displays absorption within the ultraviolet (UV) A1 spectrum and there may therefore be a potential for phototoxicity if taken during high-dose UVA1 therapy. Objectives To assess the phototoxicity risk of SJW ingestion. Methods Eleven adult volunteers of skin types I and II were exposed to a geometric dose series of UVA1 irradiation from a high-output source (Dermalight Ultra 1; Dr Honle, Martinsreid, Germany; irradiance 70-77 mW cm(-2)) on the photoprotected lower back skin at eight 1.5-cm(2) test areas. Irradiation was carried out at baseline and after 10 days of SJW extract 1020 mg (equivalent to 3000 mu g of hypericin) daily. Four, 8, 24 and 48 h after each exposure, the minimal erythema dose (MED) and the presence or absence of pigmentation were recorded visually and erythema was assessed objectively with an erythema meter. Results The median MED and D-0.025, an objective measure of MED, were lower at all time-points after SJW ingestion. The visual erythemal peak (lowest median MED), which was seen at 8 h postirradiation, was lower after SJW (median 14 J cm(-2), range 10-56) than at baseline (median 20 J cm(-2), range 14-56) (P = 0.047). Similarly, the median D-0.025 at 8 h postirradiation was lower after SJW (median 22.0 J cm(-2), range 15.2-53.9) than at baseline (median 33.7 J cm(-2), range 22.9-136.0) (P = 0.014). The MED and D-0.025 were also significantly different at the 48-h and 4-h time-points, respectively. Significance was not reached at the 24-h time-point. Median intensity of postirradiation erythema increased at all time-points after ingestion of SJW. Despite these differences, the maximum slope of the dose-response curve was not increased after SJW ingestion. Conclusions These data suggest that SJW extract has the potential to lower the erythemal threshold to UVA1 irradiation in a significant proportion of individuals and highlight the importance of ascertaining a full drug history, including herbal remedies, before initiating UVA1 phototherapy.
引用
收藏
页码:1187 / 1191
页数:5
相关论文
共 27 条
[1]
Beattie PE, 2004, BRIT J DERMATOL, V151, P106
[2]
Bernd A, 1999, PHOTOCHEM PHOTOBIOL, V69, P218, DOI 10.1111/j.1751-1097.1999.tb03276.x
[3]
Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans [J].
Brockmoller, J ;
Reum, T ;
Bauer, S ;
Kerb, R ;
Hubner, WD ;
Roots, I .
PHARMACOPSYCHIATRY, 1997, 30 :94-101
[4]
Calculation of erythema dose-response curves using a spreadsheet [J].
Davidson, AW .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 1999, 15 (3-4) :104-108
[5]
A PORTABLE INSTRUMENT FOR QUANTIFYING ERYTHEMA INDUCED BY ULTRAVIOLET-RADIATION [J].
DIFFEY, BL ;
OLIVER, RJ ;
FARR, PM .
BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 (06) :663-672
[6]
HYPERICIN AND ITS PHOTODYNAMIC-ACTION [J].
DURAN, N ;
SONG, PS .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1986, 43 (06) :677-680
[7]
Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.) [J].
Ernst, E ;
Rand, JI ;
Barnes, J ;
Stevinson, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (08) :589-594
[8]
Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: Implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders [J].
Fox, FE ;
Niu, ZT ;
Tobia, A ;
Rook, AH .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (02) :327-332
[9]
Golsch S, 1997, HAUTARZT, V48, P249, DOI 10.1007/s001050050578
[10]
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258 [J].
Gulick, RM ;
McAuliffe, V ;
Holden-Wiltse, J ;
Crumpacker, C ;
Liebes, L ;
Stein, DS ;
Meehan, P ;
Hussey, S ;
Forcht, J ;
Valentine, FT .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :510-514